05 Jun

Advanced Therapeutics in Australia

Australia is one of the top 10 countries in the world for contributions to life sciences research.

Australia’s competitive advantage Australia sees investors take innovations from the lab, through manufacturing and into clinical settings with ease.

Australia’s competitive advantage is underpinned by:

• An established healthcare system supported by globally recognised regulators.
• A vibrant innovation ecosystem with expertise and world-class infrastructure.
• Outstanding clinical trial capabilities, with streamlined regulatory pathways to expedite studies.
• Significant government support, including an R&D tax offset of up to 43.5% and A$21.5 billion in support funds for life sciences.
• An export-driven economy with 18 free trade agreements.

An ideal clinical trials destination Australia is a go-to destination for conducting clinical trials. Companies can leverage advanced capabilities in quality, speed and cost.

Globally, Australia has the third-highest rate of industry-initiated early phase clinical trials.

Australia’s success is attributed to:

• A multicultural and diverse population, supporting the breadth of clinical trial needs.
• Seasonal differences between the Northern and Southern hemisphere.
• Quality research and data, recognised by global regulators.
• Dedicated infrastructure for early-phase clinical trials.
• Efficient regulatory and ethics approval.
• Highly cost-effective R&D tax offset for eligible activities accessible to global sponsors

Learn more,  download this Australia Trade and Investment Commission guide to the Australian Life Sciences Landscape :

https://www.globalaustralia.gov.au/sites/default/files/2023-05/Advanced_Therapeutics_in_Australia_2023.pdf

Source Australian Trade and Investment Commission, Advanced Therapeutics in Australia 2023